Jayne B. Hart Myriad Genetics Inc (MYGN) insider trading activity

Jayne B. Hart is Officer of MYRIAD GENETICS INC. Currently has a direct ownership of 172,561 shares of MYGN, which is worth approximately $3.1 Million. The most recent transaction as insider was on Oct 09, 2022, when has been sold 4,926 shares (Common Stock) at a price of $19.62 per share, resulting in proceeds of $96,648. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 173K

0% 3M change

0% 12M change

Total Value Held $3.1 Million

Jayne B. Hart Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 09 2022	SELL Payment of exercise price or tax liability	$96,648 $19.62 p/Share	4,926 Reduced 2.78%	172,561 Common Stock
Sep 26 2022	SELL Payment of exercise price or tax liability	$40,797 $18.41 p/Share	2,216 Reduced 1.23%	177,487 Common Stock
Sep 25 2022	SELL Payment of exercise price or tax liability	$31,063 $18.69 p/Share	1,662 Reduced 0.92%	179,703 Common Stock
Aug 25 2022	SELL Payment of exercise price or tax liability	$28,524 $24.89 p/Share	1,146 Reduced 0.63%	181,365 Common Stock
Jun 09 2022	BUY Grant, award, or other acquisition	$15,374 $14.84 p/Share	1,036 Added 0.56%	182,511 Common Stock
Mar 24 2022	SELL Payment of exercise price or tax liability	$92,190 $25.32 p/Share	3,641 Reduced 1.97%	181,475 Common Stock
Mar 22 2022	BUY Grant, award, or other acquisition	-	19,238 Added 9.41%	185,116 Common Stock
Feb 28 2022	SELL Open market or private sale	$262,500 $25.0 p/Share	10,500 Reduced 5.95%	165,878 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	$251,790 $23.98 p/Share	10,500 Added 5.84%	169,378 Common Stock
Feb 16 2022	BUY Grant, award, or other acquisition	-	19,520 Added 10.53%	165,878 Common Stock
Nov 30 2021	BUY Grant, award, or other acquisition	$3,143 $21.98 p/Share	143 Added 0.1%	146,358 Common Stock
Oct 09 2021	SELL Payment of exercise price or tax liability	$152,115 $30.88 p/Share	4,926 Reduced 3.26%	146,215 Common Stock
Sep 26 2021	SELL Payment of exercise price or tax liability	$73,815 $33.31 p/Share	2,216 Reduced 1.97%	110,120 Common Stock
Sep 25 2021	SELL Payment of exercise price or tax liability	$129,176 $33.31 p/Share	3,878 Reduced 3.34%	112,336 Common Stock
Sep 21 2021	BUY Grant, award, or other acquisition	-	26,598 Added 18.62%	116,214 Common Stock
Sep 17 2021	SELL Open market or private sale	$2,274,279 $33.72 p/Share	67,446 Reduced 42.94%	89,616 Common Stock
Sep 17 2021	BUY Exercise of conversion of derivative security	$2,039,730 $26.49 p/Share	77,000 Added 45.41%	92,582 Common Stock
Aug 25 2021	SELL Payment of exercise price or tax liability	$39,962 $34.81 p/Share	1,148 Reduced 1.41%	80,062 Common Stock
May 28 2021	BUY Grant, award, or other acquisition	$17,161 $15.86 p/Share	1,082 Added 1.31%	81,210 Common Stock
Mar 29 2021	SELL Open market or private sale	$1,740,000 $30.0 p/Share	58,000 Reduced 41.99%	80,128 Common Stock
Mar 29 2021	BUY Exercise of conversion of derivative security	$1,338,640 $23.08 p/Share	58,000 Added 39.68%	88,162 Common Stock
Mar 24 2021	BUY Grant, award, or other acquisition	-	13,326 Added 14.26%	80,128 Common Stock
Oct 08 2020	BUY Grant, award, or other acquisition	-	17,853 Added 21.09%	66,802 Common Stock
Sep 30 2020	SELL Sale (or disposition) back to the issuer	$28,923 $13.04 p/Share	2,218 Reduced 4.33%	48,949 Common Stock

JBH

Jayne B. Hart

Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Value

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN

Account